Methylene blue, a Victorian-era medicine, is making headlines after a video of RFK Jr. using it went viral. Touted as a cure ...

Today, as part of a national initiative funded by The John A. Hartford Foundation (JAHF), the national, independent nonprofit FAIR Health launched a new shared decision-making tool for Alzheimer's ...

WashU Medicine-led trial evaluating investigational drug from Eli Lilly and Company aims to stop disease before symptoms arise Researchers at Washington University School of Medicine in St. Louis have ...

It’s a slow and painful goodbye for patients and loved ones — but some are determined to fight back. At the University of ...

Nothing arouses the ire of nursing home consumer advocates like the term antipsychotics. A class of medications that was ...

Many parts of the U.S. — including the Lakes Region — recently experienced a winter storm with more heavy snow expected over the coming days. The ...

The test could help identify one key Alzheimer's biomarker, tau protein, before it shows up in brain. Here's what experts say ...

Anavex Life Sciences Corp. expects feedback from the European Medicines Agency on blarcamesine for Alzheimer's Disease this ...

Biogen BIIB reported fourth-quarter 2024 adjusted earnings per share (EPS) of $3.44, which beat the Zacks Consensus Estimate of $3.42. Earnings rose 17% year over year on a reported basis, boosted by ...

As the body of research expands on the potential of glucagon-like peptide-1 receptor agonists to address various health ...

The Fast Track designation is supported by data from the open-label phase 1 SNK01-MX04 trial, as well as preliminary data from the phase 1 cohort from the phase 1/2a SNK01-AD01 trial.